Evaluation of anti-atherosclerotic activities of PPAR-α, PPAR-γ, and LXR agonists in hyperlipidemic atherosclerosis-susceptible F1B hamsters

Atherosclerosis

Volumn 214, Issue 1, 2011, Pages 86-93

  Srivastava, Rai Ajit K ^a  

^a Piramal Enterprises Limited   (India)

Author keywords

Animal model; Atherosclerosis; Fenofibrate; Hamster; HDL C; LDL C; LXR; PPAR; Rosiglitazone

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N (2,2,2 TRIFLUOROETHYL) N [4 (2,2,2 TRIFLUORO 1 HYDROXY 1 TRIFLUOROMETHYLETHYL)PHENYL]BENZENESULFONAMIDE; ROSIGLITAZONE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ARCH; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; FAT INTAKE; HAMSTER; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; CHOLESTEROL; CRICETINAE; FATTY ACIDS; FEMALE; FENOFIBRATE; HYDROCARBONS, FLUORINATED; HYPERLIPIDEMIAS; MALE; MESOCRICETUS; ORPHAN NUCLEAR RECEPTORS; PPAR ALPHA; PPAR GAMMA; SULFONAMIDES; THIAZOLIDINEDIONES; TRIGLYCERIDES;

EID: 78650824245     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.10.033     Document Type: Article

References (39)

1. Srivastava R.A.K., Jahagirdar R., Azhar S., Sharma S., Bisgaier C.L. Peroxisome proliferator-activated receptor-α-selective ligand reduces adiposity, improves insulin sensitivity, and inhibits atherosclerosis in LDL receptor-deficient mice. Mol Cell Biochem 2006, 285:35-50.
2. Li A.C., Binder C.J., Gutierrez A., et al. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ. J Clin Invest 2004, 114:1564-1576.
3. Duez H., Chao Y., Hernandez M., et al. Reduction of atherosclerosis by the peroxisome proliferator-activated receptor-α agonist fenofibrate in mice. J Biol Chem 2002, 277:48051-48057.
4. van der Hoogt C.C., de Haan W., Westerterp M., et al. Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression. J Lipid Res 2007, 48:1763-1771.
5. Vu-Dac N., Chopin-Delannoy S., Gervois P., et al. The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates. J Biol Chem 1998, 273:25713-25720.
6. Spady D.K., Dietschy J.M. Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat. J Lipid Res 1988, 24:303-315.
7. Dorfman S.E., Smith D.E., Osgood D.P., Lichtenstein A.H. Study on diet-induced changes in lipoprotein metabolism in two strains of Golden-Syrian hamsters. J Nutr 2003, 133:4183-4188.
8. Carpentier A., Taghibiglou C., Leung N., et al. Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in fructose-fed hamster. J Biol Chem 2002, 277:28795-28802.
9. Nistor A., Bulla A., Filip D.A., Radu A. The hyperlipidemic hamster as a model of experimental atherosclerosis. Atherosclerosis 1987, 68:159-173.
10. Guo Q., Wang P.R., Milot D.P., et al. Regulation of lipid metabolism and gene expression by fenofibrate in hamsters. Biochim Biophys Acta 2001, 1533:220-232.
11. Wang P.R., Guo Q., Ippolito M., et al. High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists. Eur J Pharmacol 2001, 21(427):285-293.
12. Ohtani H., Hayashi K., Hirata Y., et al. Effects of dietary cholesterol and fatty acids on plasma cholesterol level and hepatic lipoprotein metabolism. J Lipid Res 1990, 31:1413-1422.
13. Liu G., Fan L., Redinger R. The association of hepatic apoprotein and lipid metabolism in hamsters and rats. Comp Biochem Physiol 1991, 99A:223-228.
14. Taghibiglou C., Rudy D., Van Iderstine S.C., et al. Intracellular mechanism regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes. J Lipid Res 2000, 41:499-513.
15. Srivastava R.A.K. Increased apolipoprotein B100 mRNA by estrogen in inbred strains of mice occurs by decreased mRNA for RNA editing protein mRNA. Biochem Biophys Res Commun 1985, 212:381-387.
16. Quig D., Arbeeney C., Zilversmit D. Effects of hyperlipidemias in hamsters on lipid transfer protein activity and unidirectional cholesteryl ester transfer in plasma. Biochim Biophys Acta 1991, 1083:257-264.
17. Spady D.K., Dietschy J.M. Interaction of dietary cholesterol and triglycerides in the regulation of hepatic very low density lipoprotein transport in the hamster. J Clin Invest 1988, 81:300-309.
18. Srivastava R.A.K., Jiao S., Tang J., et al. In vivo regulation of low density lipoprotein receptor and apolipoprotein B gene expressions in inbred strains of mice by dietary fatty acids and cholesterol. Biochim Biophys Acta 1991, 1086:29-43.
19. Srivastava R.A.K. Regulation of apolipoprotein E by dietary lipids occurs by transcriptional and posttranscriptional mechanisms. Mol Cell Biochem 1996, 155:153-162.
20. Kowala M.C., Nunnari J.J., Durham S.K., Nicolosi R.J. Doxazosin and cholestyramine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamsters. Atherosclerosis 1991, 91:35-49.
21. Nicolosi R.J., Wilson T.A., Krouse B.R. The ACAT inhibitor, CI-1011 is effective in the prevention and regression of aortic fatty streak area in hamsters. Atherosclerosis 1998, 137:77-85.
22. Pitman W.A., Osgood D.P., Smith D., Schaeffer E.J., Ordovas J.M. The effect of diet and lovastatin on regression of fatty streak lesions and on hepatic and intestinal mRNA levels for LDL receptor and HMG-CoA reductase in F1B hamsters. Atherosclerosis 1998, 138:43-52.
23. McAteer M.A., Grimsditch D.C., Vidgeon-Hart M., Benson G.M., Salter A.M. Dietary cholesterol reduces lipoprotein lipase activity in the atherosclerosis-susceptible Bio F1B hamster. Br J Nutr 2003, 89:341-350.
24. Yeganeh B., Moshtaghi-Kashanian G.R., Declercq V., Moghadasian M.H. Combination of dietary phytosterols plus niacin or fenofibrate: effects on lipid profile and atherosclerosis in apoE-KO mice. J Nutr Biochem 2005, 16:222-228.
25. Declercq V., Yeganeh B., Moshtaghi-Kashanian G.R., et al. Paradoxical effects of fenofibrate and nicotinic acid in apoE-deficient mice. J Cardiovasc Pharmacol 2005, 46:18-24.
26. Kannel W.B., Castelli W.P., Gordon T., McNamara P.M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 1971, 74:1-12.
27. Brunzell J.D., Schrott H.G., Motulsky A.G., Bierman E.L. Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism 1976, 25:313-320.
28. John M., Galla J.M., Tuzcu E.M., et al. Atherogenic dyslipidemia predicts accelerated progression of atherosclerosis in patients with coronary artery disease. Circulation 2007, 116:II_285-II_286. [Abstract].
29. Dorfman S.E., Smith D.E., Osgood D.P., Lichtenstein A.H. Study of diet-induced changes in lipoprotein metabolism in two strains of Golden-Syrian hamsters. J Nutr 2003, 133:4183-4188.
30. Wilson T.A., Nicolosi R.J., Kotyla T., Sundram K., Kritchevsky D. Different palm oil preparations reduce plasma cholesterol concentrations and aortic cholesterol accumulation compared to coconut oil in hypercholesterolemic hamsters. J Nutr Biochem 2005, 16:633-640.
31. Wilson T.A., Nicolosi R.J., Lawton C.W., Babiak J. Gender differences in response to a hypercholesterolemic diet in hamsters: effects on plasma lipoprotein cholesterol concentrations and early aortic atherosclerosis. Atherosclerosis 1999, 146:83-91.
32. Mitchell P.L., Langille M.A., Currie D.L., McLeod R.S. Effect of conjugated linoleic acid isomers on lipoproteins and atherosclerosis in the Syrian Golden hamster. Biochim Biophys Acta 2005, 1734:269-276.
33. Joseph S.B., McKilligin E., Pei L., et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A 2002, 99:7604-7609.
34. Albrektsen T., Frederiksen K.S., Holmes W.E., et al. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation. Diabetes 2002, 51:1042-1051.
35. Ranganathan G., Unal R., Pokrovskaya I., et al. The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment. J Lipid Res 2006, 47:2444-2450.
36. Srivastava R.A.K., He S. Antihyperlipidemic and insulin sensitizing activities of fenofibrate reduces aortic lipid deposition in Golden Syrian Hamster. Mol Cell Biochem 2010, 345(August):197-206.
37. Otto J., Ordovas J.M., Smith D., et al. Lovastatin inhibits diet-induced atherosclerosis in F1B Golden Syrian hamsters. Atherosclerosis 1995, 114:19-28.
38. Wilson T.A., Nicolosi R.J., Rogers E.J., Sacchiero R., Goldberg D.J. Studies of cholesterol and bile acid metabolism, and early atherosclerosis in hamsters fed GT16-239, a novel bile acid sequestrant (BAS). Atherosclerosis 1998, 140:315-324.
39. Mangiapane E.H., McAteer M.A., Bensin G.M., White D.A., Salter A.M. Modulation of the regression of atherosclerosis in the hamsters by dietary lipids: comparison of coconut oil and olive oil. Br J Nutr 1999, 82:401-409.